MiMedx Group, Inc.SEC Filings
|
|
All SEC filings by MiMedx Group, Inc. (MDXG) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Jul 29, 2026 | |
| ARS | Annual report to shareholders | Apr 29, 2026 | ||
| 10-Q | Quarterly report | View Diff | Apr 29, 2026 | |
| 10-K | Annual report | View Diff | Feb 25, 2026 | |
| 10-Q | Quarterly report | View Diff | Oct 29, 2025 | |
| 10-Q | Quarterly report | View Diff | Jul 30, 2025 | |
| ARS | Annual report to shareholders | May 23, 2025 | ||
| 10-Q | Quarterly report | View Diff | Apr 30, 2025 | |
| 10-K | Annual report | View Diff | Feb 26, 2025 | |
| 10-Q | Quarterly report | View Diff | Oct 30, 2024 |
Events
| 8-K/A | Current report | Aug 11, 2026 | ||
| 8-K | Mimedx Announces Second Quarter 2026 Operating Financial Results | Jul 29, 2026 | ||
| 8-K | Mimedx to Acquire Sanara Medtech | Jul 29, 2026 | ||
| 8-K | Current report | Jun 16, 2026 | ||
| 8-K | Results of Operations and Financial Condition | Apr 29, 2026 | ||
| 8-K | Departure of Directors or Certain Officers | Apr 16, 2026 | ||
| 8-K | Results of Operations and Financial Condition | Feb 25, 2026 | ||
| 8-K | Investor Presentation January 2026 | Jan 12, 2026 | ||
| 8-K | Results of Operations and Financial Condition | Oct 29, 2025 | ||
| 8-K | Regulation Fd Disclosure | Sep 3, 2025 |
Registrations and Prospectuses
| 424B3 | Prospectus supplement | Sep 4, 2026 | ||
| S-4 | Registration of securities issued in business combination transactions | Aug 24, 2026 | ||
| 425 | Business combination disclosure | Aug 11, 2026 | ||
| 425 | Business combination disclosure | Jul 30, 2026 | ||
| 425 | Business combination disclosure | Jul 29, 2026 | ||
| 425 | Business combination disclosure | Jul 29, 2026 | ||
| 425 | Business combination disclosure | Jul 29, 2026 | ||
| 425 | Business combination disclosure | Jul 29, 2026 | ||
| 425 | Business combination disclosure | Jul 29, 2026 | ||
| S-8 | Registration of securities for employees | Jul 28, 2025 |
Proxies
| DEFA14A | Additional proxy soliciting materials | Apr 29, 2026 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 29, 2026 | |
| DEFA14A | Additional proxy soliciting materials | May 23, 2025 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 30, 2025 | |
| DEFA14A | Additional proxy soliciting materials | Apr 22, 2024 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 22, 2024 | |
| DEF 14A | Definitive proxy | View Diff | May 15, 2023 | |
| PRE 14A | Preliminary proxy | View Diff | May 4, 2023 | |
| DEFA14A | Additional proxy soliciting materials | Jun 3, 2022 | ||
| DEFA14A | Additional proxy soliciting materials | Jun 2, 2022 |
Other
| UPLOAD | Letter from SEC | Jun 4, 2024 | ||
| CORRESP | Correspondence with SEC | May 24, 2024 | ||
| UPLOAD | Letter from SEC | May 10, 2024 | ||
| EFFECT | Notice of effectiveness | Sep 8, 2021 | ||
| CORRESP | Correspondence with SEC | Sep 2, 2021 | ||
| UPLOAD | Letter from SEC | Sep 2, 2021 | ||
| UPLOAD | Letter from SEC | Apr 26, 2021 | ||
| CORRESP | Correspondence with SEC | Apr 26, 2021 | ||
| UPLOAD | Letter from SEC | Apr 26, 2021 | ||
| CERT | Certification of approval for exchange listing | Nov 3, 2020 |